Oncology Pharma Inc. (ONPH) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in San Francisco, CA, United States. The current CEO is George Malesek.
ONPH has IPO date of 1994-10-31, listed on the Other OTC, a market capitalization of $1.92M.
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
